We are live on ! Find out more
LD

Lipe & Dalton Portfolio holdings

AUM $215M
1-Year Est. Return 39.53%
This Fund
S&P 500
This Quarter Est. Return
+4.36%
1 Year Est. Return
+39.53%
3 Year Est. Return
+89.64%
5 Year Est. Return
+111.74%
10 Year Est. Return
+427.59%
AUM
$141M
AUM Growth
-$8.84M
Cap. Flow
-$2.61M
Cap. Flow %
-1.86%
Top 10 Hldgs %
38.31%
Holding
78
New
15
Increased
12
Reduced
33
Closed
3

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.25M
2
RYN icon
Rayonier
RYN
+$2.86M
3
CVX icon
Chevron
CVX
+$200K
4
AGN.PRA
Allergan plc
AGN.PRA
+$200K
5
MRK icon
Merck
MRK
+$189K

Top Sells

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$2.68M
2
SHPG
Shire pic
SHPG
+$2.67M
3
MDT icon
Medtronic
MDT
+$2.38M
4
BP icon
BP
BP
+$593K
5
BMO icon
Bank of Montreal
BMO
+$367K

Sector Composition

Rank Sector Weight
1 Financials 20.28%
2 Technology 17.51%
3 Healthcare 16.65%
4 Industrials 10.72%
5 Communication Services 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JPM icon
1
JPMorgan Chase
JPM
$939B
$6.48M 4.61%
75,114
-123
-0.2% -$9.38K
MDLZ icon
2
Mondelez International
MDLZ
$77.7B
$6.25M 4.45%
141,029
-2,270
-2% -$97.8K
AIG icon
3
American International
AIG
$41.9B
$6.25M 4.44%
95,647
-3,525
-4% -$221K
CM icon
4
Canadian Imperial Bank of Commerce
CM
$107B
$5.45M 3.88%
133,616
-2,170
-2% -$85K
MS icon
5
Morgan Stanley
MS
$337B
$5.28M 3.76%
125,015
+1,150
+0.9% +$43.5K
NXPI icon
6
NXP Semiconductors
NXPI
$68B
$5.09M 3.62%
51,945
+1,065
+2% +$106K
BIIB icon
7
Biogen
BIIB
$29.9B
$4.82M 3.43%
16,982
-85
-0.5% -$25.2K
TWX
8
DELISTED
Time Warner Inc
TWX
$4.78M 3.4%
49,534
+213
+0.4% +$19K
RTX icon
9
RTX Corp
RTX
$287B
$4.75M 3.38%
68,786
+79
+0.1% +$5.24K
INTC icon
10
Intel
INTC
$466B
$4.71M 3.35%
129,812
-3,200
-2% -$115K
TEL icon
11
TE Connectivity
TEL
$58.8B
$4.47M 3.18%
64,548
-1,175
-2% -$77.8K
AAPL icon
12
Apple
AAPL
$4.89T
$4.41M 3.14%
152,340
-1,960
-1% -$55.6K
DE icon
13
Deere & Co
DE
$170B
$4.07M 2.89%
39,477
-280
-0.7% -$26.3K
IWM icon
14
iShares Russell 2000 ETF
IWM
$80.9B
$3.82M 2.72%
28,302
-50
-0.2% -$6.39K
BAX icon
15
Baxter International
BAX
$11.6B
$3.65M 2.6%
82,298
-455
-0.5% -$21K
BP icon
16
BP
BP
$113B
$3.55M 2.53%
110,931
-19,694
-15% -$593K
IBM icon
17
IBM
IBM
$202B
$3.48M 2.48%
21,959
-803
-4% -$122K
BMY icon
18
Bristol-Myers Squibb
BMY
$127B
$3.47M 2.47%
+59,449
New +$3.25M
BN icon
19
Brookfield
BN
$102B
$3.3M 2.35%
280,458
-1,051
-0.4% -$12.8K
TUP
20
DELISTED
Tupperware Brands Corporation
TUP
$3.27M 2.33%
62,200
-5,320
-8% -$312K
TRP icon
21
TC Energy
TRP
$73.5B
$3.27M 2.33%
72,437
+2,285
+3% +$104K
DHR icon
22
Danaher
DHR
$135B
$3.25M 2.32%
47,163
-325
-0.7% -$22.6K
GOOG icon
23
Alphabet (Google) Class C
GOOG
$3.9T
$3.24M 2.31%
83,980
-80
-0.1% -$3.12K
RYN icon
24
Rayonier
RYN
$6.49B
$2.85M 2.03%
+118,084
New +$2.86M
T icon
25
AT&T
T
$165B
$2.71M 1.92%
84,246
-874
-1% -$25.8K

Similar funds

Lipe & Dalton's Q4 2016 Portfolio in Review

As of Q4 2016, Lipe & Dalton held 78 positions worth $141M, down 5.9% from $149M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Lipe & Dalton's Q4 2016 filing shows 15 new, 12 increased, 33 reduced and 3 closed positions. Its largest new stake was Bristol-Myers Squibb: 59,449 shares worth $3.47M. The largest sale was Devon Energy, an estimated $2.68M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Lipe & Dalton's largest Q4 2016 buy was Bristol-Myers Squibb: 59,449 shares worth $3.47M.
  • Lipe & Dalton added most to Allergan plc in Q4 2016, an estimated $200K increase.
  • Lipe & Dalton's biggest Q4 2016 reduction was Medtronic, cutting an estimated $2.38M.
  • Lipe & Dalton fully exited Devon Energy in Q4 2016, selling an estimated $2.68M.
  • Lipe & Dalton's ten largest holdings make up 38% of its $141M portfolio in Q4 2016.
  • Lipe & Dalton opened 15 new positions and closed 3 in Q4 2016.
  • Lipe & Dalton's portfolio value fell 5.9% quarter-over-quarter to $141M.

Based on Lipe & Dalton's 13F filing for Q4 2016, filed 10 Feb 2017.